BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 245 filers reported holding BALCHEM CORP in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $201,002 | -6.0% | 1,491 | -11.8% | 0.00% | 0.0% |
| Q1 2023 | $213,878 | -83.8% | 1,691 | -84.4% | 0.00% | -83.3% |
| Q3 2022 | $1,319,000 | -67.0% | 10,848 | -64.8% | 0.01% | -64.7% |
| Q2 2022 | $4,003,000 | -3.6% | 30,849 | +1.5% | 0.02% | +21.4% |
| Q1 2022 | $4,154,000 | +1097.1% | 30,388 | +1378.0% | 0.01% | +1300.0% |
| Q4 2021 | $347,000 | +16.8% | 2,056 | +0.3% | 0.00% | 0.0% |
| Q3 2021 | $297,000 | +6.5% | 2,049 | -3.6% | 0.00% | 0.0% |
| Q2 2021 | $279,000 | +4.9% | 2,125 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $266,000 | +24.3% | 2,125 | +14.4% | 0.00% | 0.0% |
| Q4 2020 | $214,000 | -95.1% | 1,857 | -95.9% | 0.00% | -95.5% |
| Q2 2020 | $4,346,000 | +578.0% | 45,817 | +605.7% | 0.02% | +450.0% |
| Q1 2020 | $641,000 | -84.1% | 6,492 | -83.9% | 0.00% | -73.3% |
| Q2 2019 | $4,022,000 | +6.4% | 40,235 | -1.2% | 0.02% | +7.1% |
| Q1 2019 | $3,779,000 | +50.1% | 40,722 | +81.3% | 0.01% | +55.6% |
| Q3 2018 | $2,518,000 | -29.4% | 22,464 | -38.1% | 0.01% | -40.0% |
| Q2 2018 | $3,565,000 | +145.4% | 36,318 | +104.4% | 0.02% | +114.3% |
| Q1 2018 | $1,453,000 | – | 17,771 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANTA MONICA PARTNERS LP | 203,004 | $25,181 | 19.44% |
| Montanaro Asset Management Ltd | 188,000 | $23,319,520 | 4.10% |
| Conestoga Capital Advisors, LLC | 1,076,327 | $133,507,648 | 2.29% |
| GENEVA CAPITAL MANAGEMENT LLC | 763,326 | $94,682,937 | 2.00% |
| Tributary Capital Management, LLC | 139,116 | $17,255,949 | 1.63% |
| WASATCH ADVISORS LP | 1,976,930 | $245,218,397 | 1.55% |
| Cutter & CO Brokerage, Inc. | 41,853 | $5,191,409 | 1.52% |
| Laurus Investment Counsel Inc. | 19,990 | $3,342,174 | 1.40% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 37,950 | $4,707,318 | 0.97% |
| MOODY ALDRICH PARTNERS LLC | 36,613 | $4,541,477 | 0.86% |